Growing Prevalence Of Chronic Diseases In Children Boosts Pediatric Vaccine Market: A Significant Driver Propelling The Pediatric Vaccine Market In 2025

The Pediatric Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Pediatric Vaccine Market Size and Projected Growth Rate?
The size of the pediatric vaccine market has seen a swift expansion in the past few years. The market is projected to inflate from $45.9 billion in 2024 to $51.56 billion in 2025, with a compound annual growth rate (CAGR) of 12.3%. This significant upturn during the historic period can be ascribed to the rising occurrence of chronic diseases, the implementation of immunization policies aimed at eliminating endemic diseases, and bolstered financial backing for the development of vaccines.

The market for pediatric vaccines is projected to experience significant expansion in the coming years, with expectations for the market to reach $85.3 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 13.4%. This anticipated surge within the forecasted period is primarily attributed to the rise in invasive cervical cancer cases, a solid late-stage pipeline and fresh drug approvals, along with an increased occurrence of infectious diseases. The forthcoming period is forecasted to witness major trends such as the development of combination vaccines to fulfill market requirements, investments in research and development activities for the production of effective vaccines. There is also a focus on the creation of live attenuated vaccines, the use of innovative immune engineering and advanced delivery systems, and the incorporation of artificial intelligence (AI) in vaccine production to streamline the process and ease manufacturing.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2824

What Are the Major Segments in the Pediatric Vaccine Market?
The pediatric vaccine market covered in this report is segmented -

1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies
3) By Application: Infectious Disease, Allergy, Cancer

Subsegments:
1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines
2) By Multivalent: Combination Vaccines, Polyvalent Vaccines

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2824&type=smp

What Are The Driving Pediatric Vaccine Market Evolution?
The growth of the pediatric vaccines market will be boosted by the increasing incidence of chronic illnesses such as tuberculosis, diphtheria, and pneumonia in the age demographic below 15 years. There is a rising risk of severe disease outcomes and complications from infectious diseases in children and teenagers with chronic health conditions. In March 2022, the Australian Bureau of Statistics, an autonomous statutory body based in Australia tasked with collecting, assessing data, and offering factual recommendations, disclosed that roughly half the total population, equating to 46.6% or 11.6 million people, had at least one chronic condition. The growing prevalence of these chronic diseases in children enhances the need for immunity against them. Consequently, it propels the growth of the pediatric vaccine market.

Which Firms Dominate The Pediatric Vaccine Market Segments?
Major companies operating in the pediatric vaccine market include Merck & Co. Inc., Serum Institute of India Pvt. Ltd., Sanofi SA, Pfizer Inc., AstraZeneca, GlaxoSmithKline PLC, Sinovac Biotech Ltd, Zydus Cadila, Indian Immunologicals Limited, Panacea Biotec, Takeda Pharmaceutical Company, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo, CSL Limited, BIO-MED, Sun Pharmaceutical Industries Ltd, Sinopharm, Walvax biotechnology, Fosun Pharma, BioNTech, MCM Vaccine Company, Seqirus, Roche, Johnson & Johnson, Novartis, Connaught LaboratoriesInc., Wyeth-Ayerst, Grifols, Ataulfo de Paiva Foundation, Bio-Manguinhos-Institute of Technology on Immunobiologicals, Butantan Institute, Ezequiel Dias Foundation (FUNED), Sinergium

What Trends Are Driving Growth in The Pediatric Vaccine Market?
There is a consistent increase in the need for innovative vaccines to offer enhanced protection against difficult infectious diseases such as tuberculosis and HIV/ AIDS, as well as non-infectious chronic diseases like cancer and neurodegenerative diseases. The evolution of vaccine development encompasses the design of structural immunogenic, gene-based vaccine platforms, and efficient adjuvant recombinant antigen formulations. To cater to the rising need for innovative vaccines, there is a relentless pursuit among pediatric vaccine manufacturers and developers to promote vaccine design and production technologies. For example, in April 2023, U.S. pharmaceutical manufacturer Pfizer Inc. revealed the approval of REVNAR 20, a 20-valent Pneumococcal Conjugate Vaccine for children and infants by the U.S. FDA.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Which Is The Largest Region In The Pediatric Vaccine Market?
North America was the largest region in the pediatric vaccine market in 2024. Middle East is expected to be the largest growing region in the global pediatric vaccine market share during the forecast period. The regions covered in the pediatric vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Pediatric Vaccine Market?
2. What is the CAGR expected in the Pediatric Vaccine Market?
3. What Are the Key Innovations Transforming the Pediatric Vaccine Industry?
4. Which Region Is Leading the Pediatric Vaccine Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.